Image

Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female

Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female

Recruiting
25-40 years
Female
Phase N/A

Powered by AI

Overview

The purpose of this study was to investigate the effect of ultrasound cavitation on insulin resistance, HbA1c and skin fold in patients with abdominal central obesity.

Description

Few researchers have detected the effects of ultrasonic cavitation on insulin resistance in subjects with central obesity. However, there were many conflicts and no clear evidence in the literature concerning the superiority of cavitation on body contour adjustment. Consequently, this study aimed to investigate the effects of ultrasound cavitation, aerobic exercise and a low-calorie dietary program on insulin resistance and total plasma HOMA ir and body contouring in female with abdominal obesity.

Eligibility

Inclusion Criteria:

  • Female subjects with central obesity.
  • Female participants aged between 25 to 40 years.
  • Body Mass Index (BMI) ranged from 30 to 35 kg/m2 as high BMI indicates more obesity and central obesity.
  • Waist circumference greater than 88 cm, indicative of abdominal obesity.
  • Diagnosed with insulin resistance (HOMA-IR > 2.9).
  • Sedentary lifestyle, defined as engaging in less than 150 minutes of moderate-intensity physical activity per week.
  • Willingness to provide informed consent and comply with study procedures.

Exclusion Criteria:

  • • Subjects diagnosed with DM (HbA1c more than 6.5%).
    • History of metabolic disorders such as type 1 diabetes or thyroid disorders.
    • Subjects with BMI less than 30 kg/m2.
    • Subjects diagnosed with heart disease, liver as well as kidney diseases.
    • Subjects who take oral contraceptives.
    • Subjects with gestational Diabetes.
    • Pregnant or breastfeeding women were excluded from the study.
    • Use of weight-loss medications or supplements within the past six months.
    • Previous surgical procedures for weight loss or body contouring.
    • Contraindications to ultrasound therapy (e.g., metal implants in the abdomen, active skin infections).
    • Participation in another clinical trial within the last three months.

Study details
    Central Obesity

NCT06729203

Cairo University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.